▶ 調査レポート

豚生殖・呼吸器症候群ワクチンの世界及び中国市場

• 英文タイトル:Global and China Swine Reproductive and Respiratory Syndrome Vaccine Market Insights, Forecast to 2027

QYResearchが調査・発行した産業分析レポートです。豚生殖・呼吸器症候群ワクチンの世界及び中国市場 / Global and China Swine Reproductive and Respiratory Syndrome Vaccine Market Insights, Forecast to 2027 / QY2108PAL8944資料のイメージです。• レポートコード:QY2108PAL8944
• 出版社/出版日:QYResearch / 2021年6月
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、156ページ
• 納品方法:Eメール(納期:1日)
• 産業分類:医薬品
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Multi User¥865,800 (USD5,850)▷ お問い合わせ
  Enterprise License¥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の当調査資料ではグローバルにおける豚生殖・呼吸器症候群ワクチンの市場規模(2016年-2027年)と動向についてまとめました。中国市場については主要プレイヤーの市場シェア、豚生殖・呼吸器症候群ワクチンの種類別市場規模(活性ワクチン、不活化ワクチン)、用途別市場規模(政府入札、市場販売)も掲載しています。他に、北米・アメリカ市場、ヨーロッパ市場、アジア太平洋・日本市場、中南米市場、中東・アフリカ市場の市場規模、グローバル市場機会・課題・リスク要因、バリューチェーン・販売チャネル、主要プレイヤーの情報なども掲載しています。
・調査の概要
・調査のサマリー
・世界の豚生殖・呼吸器症候群ワクチン市場動向
・グローバル主要プレイヤーの競争状況・市場シェア
・世界における豚生殖・呼吸器症候群ワクチンの種類別市場規模(2016年-2027年):活性ワクチン、不活化ワクチン
・世界における豚生殖・呼吸器症候群ワクチンの用途別市場規模(2016年-2027年):政府入札、市場販売
・豚生殖・呼吸器症候群ワクチンの中国市場分析
- 豚生殖・呼吸器症候群ワクチンの中国市場規模(2016年-2027年)
- 中国における豚生殖・呼吸器症候群ワクチンの主要プレイヤー別市場シェア
- 中国における豚生殖・呼吸器症候群ワクチンの種類別市場規模:活性ワクチン、不活化ワクチン
- 中国における豚生殖・呼吸器症候群ワクチンの用途別市場規模:政府入札、市場販売
・豚生殖・呼吸器症候群ワクチンの北米市場(2016年-2027年)
・豚生殖・呼吸器症候群ワクチンのヨーロッパ市場(2016年-2027年)
・豚生殖・呼吸器症候群ワクチンのアジア太平洋市場(2016年-2027年)
・豚生殖・呼吸器症候群ワクチンの中南米市場(2016年-2027年)
・豚生殖・呼吸器症候群ワクチンの中東・アフリカ市場(2016年-2027年)
・主要プレイヤーの情報:ASCENT CORPORATION、Boehringer-Ingelheim、MSD Animal Health、SPAH、Ceva、Chengdu TECH-BANK Biological Products Co,.Ltd、ringpu、QILU ANIMAL HEALTH PRODUCTS CO.,LTD、DAHUANONG、CAVAC、Komipharm、Agrovet、Bioveta、JINYU BIO-TECNOLOGY CO.,LTD、Phibro Animal Health、ANHUI TIANKANG(GROUP)SHRES O., LTD、Zoetis、WINSUN BIO、PULIKE BIOLOGICAL ENGINERING,INC.
・市場機会・課題・リスク要因分析
・バリューチェーン・販売チャネル分析
・...

Swine reproductive and respiratory syndrome is an acute and highly contagious viral infection characterized by reproductive disorder and respiratory symptoms in pig population.
Boehringer ingelheim is the company with the largest market share, about 25 percent.

Market Analysis and Insights: Global and China Swine Reproductive and Respiratory Syndrome Vaccine Market
This report focuses on global and China Swine Reproductive and Respiratory Syndrome Vaccine market.
In 2020, the global Swine Reproductive and Respiratory Syndrome Vaccine market size was US$ 385.1 million and it is expected to reach US$ 760.2 million by the end of 2027, with a CAGR of 10.2% during 2021-2027. In China the Swine Reproductive and Respiratory Syndrome Vaccine market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Swine Reproductive and Respiratory Syndrome Vaccine Scope and Market Size
Swine Reproductive and Respiratory Syndrome Vaccine market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Swine Reproductive and Respiratory Syndrome Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Swine Reproductive and Respiratory Syndrome Vaccine market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.

Segment by Type
Active Vaccine
Inactivated Vaccines
The segment of active vaccine holds a comparatively larger share in global market, which accounts for about 90%.

Segment by Application
Government Tender
Market Sales
The vaccine is fully applicated in market sales.

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
ASCENT CORPORATION
Boehringer-Ingelheim
MSD Animal Health
SPAH
Ceva
Chengdu TECH-BANK Biological Products Co,.Ltd
ringpu
QILU ANIMAL HEALTH PRODUCTS CO.,LTD
DAHUANONG
CAVAC
Komipharm
Agrovet
Bioveta
JINYU BIO-TECNOLOGY CO.,LTD
Phibro Animal Health
ANHUI TIANKANG(GROUP)SHRES O., LTD
Zoetis
WINSUN BIO
PULIKE BIOLOGICAL ENGINERING,INC.

レポート目次

1 Study Coverage
1.1 Swine Reproductive and Respiratory Syndrome Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Market Size Growth Rate by Type
1.2.2 Active Vaccine
1.2.3 Inactivated Vaccines
1.3 Market by Application
1.3.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Market Size Growth Rate by Application
1.3.2 Government Tender
1.3.3 Market Sales
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Market Size, Estimates and Forecasts
2.1.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue 2016-2027
2.1.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales 2016-2027
2.2 Global Swine Reproductive and Respiratory Syndrome Vaccine, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Swine Reproductive and Respiratory Syndrome Vaccine Historical Market Size by Region (2016-2021)
2.3.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Swine Reproductive and Respiratory Syndrome Vaccine Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Forecast by Region (2022-2027)
2.4.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Forecast by Region (2022-2027)

3 Global Swine Reproductive and Respiratory Syndrome Vaccine Competitor Landscape by Players
3.1 Global Top Swine Reproductive and Respiratory Syndrome Vaccine Manufacturers by Sales
3.1.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Manufacturer (2016-2021)
3.1.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Swine Reproductive and Respiratory Syndrome Vaccine Manufacturers by Revenue
3.2.1 Key Swine Reproductive and Respiratory Syndrome Vaccine Manufacturers Covered: Ranking by Revenue
3.2.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Manufacturers (2016-2021)
3.2.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Swine Reproductive and Respiratory Syndrome Vaccine Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Swine Reproductive and Respiratory Syndrome Vaccine Revenue in 2020
3.2.6 Global Swine Reproductive and Respiratory Syndrome Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Price by Manufacturers
3.4 Global Swine Reproductive and Respiratory Syndrome Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Swine Reproductive and Respiratory Syndrome Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Swine Reproductive and Respiratory Syndrome Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Swine Reproductive and Respiratory Syndrome Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2027)
4.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Type (2016-2021)
4.1.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type (2016-2021)
4.1.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Type (2016-2021)
4.1.3 Swine Reproductive and Respiratory Syndrome Vaccine Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Market Size Forecast by Type (2022-2027)
4.2.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Forecast by Type (2022-2027)
4.2.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Forecast by Type (2022-2027)
4.2.3 Swine Reproductive and Respiratory Syndrome Vaccine Average Selling Price (ASP) Forecast by Type (2022-2027)

5 Breakdown Data by Application (2016-2027)
5.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Application (2016-2021)
5.1.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application (2016-2021)
5.1.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Application (2016-2021)
5.1.3 Swine Reproductive and Respiratory Syndrome Vaccine Price by Application (2016-2021)
5.2 Swine Reproductive and Respiratory Syndrome Vaccine Market Size Forecast by Application (2022-2027)
5.2.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Forecast by Application (2022-2027)
5.2.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Forecast by Application (2022-2027)
5.2.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Price Forecast by Application (2022-2027)

6 China by Players, Type and Application
6.1 China Swine Reproductive and Respiratory Syndrome Vaccine Market Size YoY Growth 2016-2027
6.1.1 China Swine Reproductive and Respiratory Syndrome Vaccine Sales YoY Growth 2016-2027
6.1.2 China Swine Reproductive and Respiratory Syndrome Vaccine Revenue YoY Growth 2016-2027
6.1.3 China Swine Reproductive and Respiratory Syndrome Vaccine Market Share in Global Market 2016-2027
6.2 China Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Players (International and Local Players)
6.2.1 China Top Swine Reproductive and Respiratory Syndrome Vaccine Players by Sales (2016-2021)
6.2.2 China Top Swine Reproductive and Respiratory Syndrome Vaccine Players by Revenue (2016-2021)
6.3 China Swine Reproductive and Respiratory Syndrome Vaccine Historic Market Review by Type (2016-2021)
6.3.1 China Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Type (2016-2021)
6.3.2 China Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Type (2016-2021)
6.3.3 China Swine Reproductive and Respiratory Syndrome Vaccine Price by Type (2016-2021)
6.4 China Swine Reproductive and Respiratory Syndrome Vaccine Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Swine Reproductive and Respiratory Syndrome Vaccine Sales Forecast by Type (2022-2027)
6.4.2 China Swine Reproductive and Respiratory Syndrome Vaccine Revenue Forecast by Type (2022-2027)
6.4.3 China Swine Reproductive and Respiratory Syndrome Vaccine Price Forecast by Type (2022-2027)
6.5 China Swine Reproductive and Respiratory Syndrome Vaccine Historic Market Review by Application (2016-2021)
6.5.1 China Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Application (2016-2021)
6.5.2 China Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Application (2016-2021)
6.5.3 China Swine Reproductive and Respiratory Syndrome Vaccine Price by Application (2016-2021)
6.6 China Swine Reproductive and Respiratory Syndrome Vaccine Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Swine Reproductive and Respiratory Syndrome Vaccine Sales Forecast by Application (2022-2027)
6.6.2 China Swine Reproductive and Respiratory Syndrome Vaccine Revenue Forecast by Application (2022-2027)
6.6.3 China Swine Reproductive and Respiratory Syndrome Vaccine Price Forecast by Application (2022-2027)

7 North America
7.1 North America Swine Reproductive and Respiratory Syndrome Vaccine Market Size YoY Growth 2016-2027
7.2 North America Swine Reproductive and Respiratory Syndrome Vaccine Market Facts & Figures by Country
7.2.1 North America Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2016-2021)
7.2.2 North America Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada

8 Asia Pacific
8.1 Asia Pacific Swine Reproductive and Respiratory Syndrome Vaccine Market Size YoY Growth 2016-2027
8.2 Asia Pacific Swine Reproductive and Respiratory Syndrome Vaccine Market Facts & Figures by Region
8.2.1 Asia Pacific Swine Reproductive and Respiratory Syndrome Vaccine Sales by Region (2016-2021)
8.2.2 Asia Pacific Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam

9 Europe
9.1 Europe Swine Reproductive and Respiratory Syndrome Vaccine Market Size YoY Growth 2016-2027
9.2 Europe Swine Reproductive and Respiratory Syndrome Vaccine Market Facts & Figures by Country
9.2.1 Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2016-2021)
9.2.2 Europe Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy

10 Latin America
10.1 Latin America Swine Reproductive and Respiratory Syndrome Vaccine Market Size YoY Growth 2016-2027
10.2 Latin America Swine Reproductive and Respiratory Syndrome Vaccine Market Facts & Figures by Country
10.2.1 Latin America Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2016-2021)
10.2.2 Latin America Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Market Facts & Figures by Country
11.2.1 Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2016-2021)
11.2.2 Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE

12 Company Profiles
12.1 ASCENT CORPORATION
12.1.1 ASCENT CORPORATION Corporation Information
12.1.2 ASCENT CORPORATION Description and Business Overview
12.1.3 ASCENT CORPORATION Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.1.4 ASCENT CORPORATION Swine Reproductive and Respiratory Syndrome Vaccine Products Offered
12.1.5 ASCENT CORPORATION Recent Development
12.2 Boehringer-Ingelheim
12.2.1 Boehringer-Ingelheim Corporation Information
12.2.2 Boehringer-Ingelheim Description and Business Overview
12.2.3 Boehringer-Ingelheim Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Boehringer-Ingelheim Swine Reproductive and Respiratory Syndrome Vaccine Products Offered
12.2.5 Boehringer-Ingelheim Recent Development
12.3 MSD Animal Health
12.3.1 MSD Animal Health Corporation Information
12.3.2 MSD Animal Health Description and Business Overview
12.3.3 MSD Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.3.4 MSD Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Products Offered
12.3.5 MSD Animal Health Recent Development
12.4 SPAH
12.4.1 SPAH Corporation Information
12.4.2 SPAH Description and Business Overview
12.4.3 SPAH Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.4.4 SPAH Swine Reproductive and Respiratory Syndrome Vaccine Products Offered
12.4.5 SPAH Recent Development
12.5 Ceva
12.5.1 Ceva Corporation Information
12.5.2 Ceva Description and Business Overview
12.5.3 Ceva Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Ceva Swine Reproductive and Respiratory Syndrome Vaccine Products Offered
12.5.5 Ceva Recent Development
12.6 Chengdu TECH-BANK Biological Products Co,.Ltd
12.6.1 Chengdu TECH-BANK Biological Products Co,.Ltd Corporation Information
12.6.2 Chengdu TECH-BANK Biological Products Co,.Ltd Description and Business Overview
12.6.3 Chengdu TECH-BANK Biological Products Co,.Ltd Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Chengdu TECH-BANK Biological Products Co,.Ltd Swine Reproductive and Respiratory Syndrome Vaccine Products Offered
12.6.5 Chengdu TECH-BANK Biological Products Co,.Ltd Recent Development
12.7 ringpu
12.7.1 ringpu Corporation Information
12.7.2 ringpu Description and Business Overview
12.7.3 ringpu Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.7.4 ringpu Swine Reproductive and Respiratory Syndrome Vaccine Products Offered
12.7.5 ringpu Recent Development
12.8 QILU ANIMAL HEALTH PRODUCTS CO.,LTD
12.8.1 QILU ANIMAL HEALTH PRODUCTS CO.,LTD Corporation Information
12.8.2 QILU ANIMAL HEALTH PRODUCTS CO.,LTD Description and Business Overview
12.8.3 QILU ANIMAL HEALTH PRODUCTS CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.8.4 QILU ANIMAL HEALTH PRODUCTS CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Products Offered
12.8.5 QILU ANIMAL HEALTH PRODUCTS CO.,LTD Recent Development
12.9 DAHUANONG
12.9.1 DAHUANONG Corporation Information
12.9.2 DAHUANONG Description and Business Overview
12.9.3 DAHUANONG Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.9.4 DAHUANONG Swine Reproductive and Respiratory Syndrome Vaccine Products Offered
12.9.5 DAHUANONG Recent Development
12.10 CAVAC
12.10.1 CAVAC Corporation Information
12.10.2 CAVAC Description and Business Overview
12.10.3 CAVAC Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.10.4 CAVAC Swine Reproductive and Respiratory Syndrome Vaccine Products Offered
12.10.5 CAVAC Recent Development
12.11 ASCENT CORPORATION
12.11.1 ASCENT CORPORATION Corporation Information
12.11.2 ASCENT CORPORATION Description and Business Overview
12.11.3 ASCENT CORPORATION Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.11.4 ASCENT CORPORATION Swine Reproductive and Respiratory Syndrome Vaccine Products Offered
12.11.5 ASCENT CORPORATION Recent Development
12.12 Agrovet
12.12.1 Agrovet Corporation Information
12.12.2 Agrovet Description and Business Overview
12.12.3 Agrovet Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Agrovet Products Offered
12.12.5 Agrovet Recent Development
12.13 Bioveta
12.13.1 Bioveta Corporation Information
12.13.2 Bioveta Description and Business Overview
12.13.3 Bioveta Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Bioveta Products Offered
12.13.5 Bioveta Recent Development
12.14 JINYU BIO-TECNOLOGY CO.,LTD
12.14.1 JINYU BIO-TECNOLOGY CO.,LTD Corporation Information
12.14.2 JINYU BIO-TECNOLOGY CO.,LTD Description and Business Overview
12.14.3 JINYU BIO-TECNOLOGY CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.14.4 JINYU BIO-TECNOLOGY CO.,LTD Products Offered
12.14.5 JINYU BIO-TECNOLOGY CO.,LTD Recent Development
12.15 Phibro Animal Health
12.15.1 Phibro Animal Health Corporation Information
12.15.2 Phibro Animal Health Description and Business Overview
12.15.3 Phibro Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Phibro Animal Health Products Offered
12.15.5 Phibro Animal Health Recent Development
12.16 ANHUI TIANKANG(GROUP)SHRES O., LTD
12.16.1 ANHUI TIANKANG(GROUP)SHRES O., LTD Corporation Information
12.16.2 ANHUI TIANKANG(GROUP)SHRES O., LTD Description and Business Overview
12.16.3 ANHUI TIANKANG(GROUP)SHRES O., LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.16.4 ANHUI TIANKANG(GROUP)SHRES O., LTD Products Offered
12.16.5 ANHUI TIANKANG(GROUP)SHRES O., LTD Recent Development
12.17 Zoetis
12.17.1 Zoetis Corporation Information
12.17.2 Zoetis Description and Business Overview
12.17.3 Zoetis Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.17.4 Zoetis Products Offered
12.17.5 Zoetis Recent Development
12.18 WINSUN BIO
12.18.1 WINSUN BIO Corporation Information
12.18.2 WINSUN BIO Description and Business Overview
12.18.3 WINSUN BIO Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.18.4 WINSUN BIO Products Offered
12.18.5 WINSUN BIO Recent Development
12.19 PULIKE BIOLOGICAL ENGINERING,INC.
12.19.1 PULIKE BIOLOGICAL ENGINERING,INC. Corporation Information
12.19.2 PULIKE BIOLOGICAL ENGINERING,INC. Description and Business Overview
12.19.3 PULIKE BIOLOGICAL ENGINERING,INC. Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.19.4 PULIKE BIOLOGICAL ENGINERING,INC. Products Offered
12.19.5 PULIKE BIOLOGICAL ENGINERING,INC. Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Swine Reproductive and Respiratory Syndrome Vaccine Industry Trends
13.2 Swine Reproductive and Respiratory Syndrome Vaccine Market Drivers
13.3 Swine Reproductive and Respiratory Syndrome Vaccine Market Challenges
13.4 Swine Reproductive and Respiratory Syndrome Vaccine Market Restraints

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Swine Reproductive and Respiratory Syndrome Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Global Swine Reproductive and Respiratory Syndrome Vaccine Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Active Vaccine
Table 3. Major Manufacturers of Inactivated Vaccines
Table 4. Global Swine Reproductive and Respiratory Syndrome Vaccine Market Size Growth Rate by Application (2021-2027) & (K Units)
Table 5. Global Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 6. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Regions (2016-2021) & (K Units)
Table 7. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Regions (2016-2021)
Table 8. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Regions (2016-2021) & (US$ Million)
Table 9. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Forecast by Region (2022-2027) & (K Units)
Table 10. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share Forecast by Region (2022-2027)
Table 11. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 12. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share Forecast by Region (2022-2027)
Table 13. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Manufacturers (2016-2021) (K Units)
Table 14. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Share by Manufacturers (2016-2021)
Table 15. Ranking of Global Top Swine Reproductive and Respiratory Syndrome Vaccine Manufacturers by Revenue (US$ Million) in 2020
Table 16. Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Manufacturers (2016-2021) (US$ Million)
Table 17. Swine Reproductive and Respiratory Syndrome Vaccine Revenue Share by Manufacturers (2016-2021)
Table 18. Global Swine Reproductive and Respiratory Syndrome Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 19. Global Swine Reproductive and Respiratory Syndrome Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Swine Reproductive and Respiratory Syndrome Vaccine as of 2020)
Table 20. Key Manufacturers Swine Reproductive and Respiratory Syndrome Vaccine Price (2016-2021) (USD/Unit)
Table 21. Swine Reproductive and Respiratory Syndrome Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Swine Reproductive and Respiratory Syndrome Vaccine Product Type
Table 23. Date of International Manufacturers Enter into Swine Reproductive and Respiratory Syndrome Vaccine Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type (2016-2021) (K Units)
Table 26. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Share by Type (2016-2021)
Table 27. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Type (2016-2021) (US$ Million)
Table 28. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Share by Type (2016-2021)
Table 29. Swine Reproductive and Respiratory Syndrome Vaccine Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit)
Table 30. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Forecast by Type (2022-2027) & (K Units)
Table 31. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share Forecast by Type (2022-2027)
Table 32. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Forecast V (2022-2027) & (US$ Million)
Table 33. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share Forecast by Type (2022-2027)
Table 34. Global Swine Reproductive and Respiratory Syndrome Vaccine Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Unit)
Table 35. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application (2016-2021) (K Units)
Table 36. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Share by Application (2016-2021)
Table 37. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Application (2016-2021) (US$ Million)
Table 38. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Share by Application (2016-2021)
Table 39. Swine Reproductive and Respiratory Syndrome Vaccine Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit)
Table 40. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Forecast by Application (2022-2027) & (K Units)
Table 41. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share Forecast by Application (2022-2027)
Table 42. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 43. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share Forecast by Application (2022-2027)
Table 44. Global Swine Reproductive and Respiratory Syndrome Vaccine Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Unit)
Table 45. China Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units) of Key Companies (2016-2021)
Table 46. China Swine Reproductive and Respiratory Syndrome Vaccine Sales Share by Company (2016-2021)
Table 47. China Swine Reproductive and Respiratory Syndrome Vaccine Revenue (US$ Million) by Company (2016-2021)
Table 48. China Swine Reproductive and Respiratory Syndrome Vaccine Revenue Share by Company (2016-2021)
Table 49. China Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units) by Type (2016-2021)
Table 50. China Swine Reproductive and Respiratory Syndrome Vaccine Sales Share by Type (2016-2021)
Table 51. China Swine Reproductive and Respiratory Syndrome Vaccine Revenue (US$ Million) Market Share by Type (2016-2021)
Table 52. China Swine Reproductive and Respiratory Syndrome Vaccine Price (USD/Unit) by Type (2016-2021)
Table 53. China Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units) by Type (2022-2027)
Table 54. China Swine Reproductive and Respiratory Syndrome Vaccine Sales Share by Type (2022-2027)
Table 55. China Swine Reproductive and Respiratory Syndrome Vaccine Revenue (US$ Million) Market Share by Type (2022-2027)
Table 56. China Swine Reproductive and Respiratory Syndrome Vaccine Revenue Share by Type (2022-2027)
Table 57. China Swine Reproductive and Respiratory Syndrome Vaccine Price (USD/Unit) by Type (2022-2027)
Table 58. China Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units) by Application (2016-2021)
Table 59. China Swine Reproductive and Respiratory Syndrome Vaccine Sales Share by Application (2016-2021)
Table 60. China Swine Reproductive and Respiratory Syndrome Vaccine Revenue (US$ Million) Market Share by Application (2016-2021)
Table 61. China Swine Reproductive and Respiratory Syndrome Vaccine Price (USD/Unit) by Application (2016-2021)
Table 62. China Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units) by Application (2022-2027)
Table 63. China Swine Reproductive and Respiratory Syndrome Vaccine Sales Share by Application (2022-2027)
Table 64. China Swine Reproductive and Respiratory Syndrome Vaccine Revenue (US$ Million) Market Share by Application (2022-2027)
Table 65. China Swine Reproductive and Respiratory Syndrome Vaccine Revenue Share by Application (2022-2027)
Table 66. China Swine Reproductive and Respiratory Syndrome Vaccine Price (USD/Unit) by Application (2022-2027)
Table 67. North America Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2016-2021) & (K Units)
Table 68. North America Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Country (2016-2021)
Table 69. North America Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 70. North America Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Country (2016-2021)
Table 71. Asia Pacific Swine Reproductive and Respiratory Syndrome Vaccine Sales by Region (2016-2021) & (K Units)
Table 72. Asia Pacific Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Region (2016-2021)
Table 73. Asia Pacific Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 74. Asia Pacific Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Region (2016-2021)
Table 75. Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2016-2021) & (K Units)
Table 76. Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Country (2016-2021)
Table 77. Europe Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 78. Europe Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Country (2016-2021)
Table 79. Latin America Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2016-2021) & (K Units)
Table 80. Latin America Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Country (2016-2021)
Table 81. Latin Americaa Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 82. Latin America Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Country (2016-2021)
Table 83. Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2016-2021) & (K Units)
Table 84. Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Country (2016-2021)
Table 85. Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 86. Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Country (2016-2021)
Table 87. ASCENT CORPORATION Corporation Information
Table 88. ASCENT CORPORATION Description and Business Overview
Table 89. ASCENT CORPORATION Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 90. ASCENT CORPORATION Swine Reproductive and Respiratory Syndrome Vaccine Product
Table 91. ASCENT CORPORATION Recent Development
Table 92. Boehringer-Ingelheim Corporation Information
Table 93. Boehringer-Ingelheim Description and Business Overview
Table 94. Boehringer-Ingelheim Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 95. Boehringer-Ingelheim Product
Table 96. Boehringer-Ingelheim Recent Development
Table 97. MSD Animal Health Corporation Information
Table 98. MSD Animal Health Description and Business Overview
Table 99. MSD Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 100. MSD Animal Health Product
Table 101. MSD Animal Health Recent Development
Table 102. SPAH Corporation Information
Table 103. SPAH Description and Business Overview
Table 104. SPAH Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 105. SPAH Product
Table 106. SPAH Recent Development
Table 107. Ceva Corporation Information
Table 108. Ceva Description and Business Overview
Table 109. Ceva Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 110. Ceva Product
Table 111. Ceva Recent Development
Table 112. Chengdu TECH-BANK Biological Products Co,.Ltd Corporation Information
Table 113. Chengdu TECH-BANK Biological Products Co,.Ltd Description and Business Overview
Table 114. Chengdu TECH-BANK Biological Products Co,.Ltd Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 115. Chengdu TECH-BANK Biological Products Co,.Ltd Product
Table 116. Chengdu TECH-BANK Biological Products Co,.Ltd Recent Development
Table 117. ringpu Corporation Information
Table 118. ringpu Description and Business Overview
Table 119. ringpu Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 120. ringpu Product
Table 121. ringpu Recent Development
Table 122. QILU ANIMAL HEALTH PRODUCTS CO.,LTD Corporation Information
Table 123. QILU ANIMAL HEALTH PRODUCTS CO.,LTD Description and Business Overview
Table 124. QILU ANIMAL HEALTH PRODUCTS CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 125. QILU ANIMAL HEALTH PRODUCTS CO.,LTD Product
Table 126. QILU ANIMAL HEALTH PRODUCTS CO.,LTD Recent Development
Table 127. DAHUANONG Corporation Information
Table 128. DAHUANONG Description and Business Overview
Table 129. DAHUANONG Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 130. DAHUANONG Product
Table 131. DAHUANONG Recent Development
Table 132. CAVAC Corporation Information
Table 133. CAVAC Description and Business Overview
Table 134. CAVAC Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 135. CAVAC Product
Table 136. CAVAC Recent Development
Table 137. Komipharm Corporation Information
Table 138. Komipharm Description and Business Overview
Table 139. Komipharm Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 140. Komipharm Product
Table 141. Komipharm Recent Development
Table 142. Agrovet Corporation Information
Table 143. Agrovet Description and Business Overview
Table 144. Agrovet Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 145. Agrovet Product
Table 146. Agrovet Recent Development
Table 147. Bioveta Corporation Information
Table 148. Bioveta Description and Business Overview
Table 149. Bioveta Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 150. Bioveta Product
Table 151. Bioveta Recent Development
Table 152. JINYU BIO-TECNOLOGY CO.,LTD Corporation Information
Table 153. JINYU BIO-TECNOLOGY CO.,LTD Description and Business Overview
Table 154. JINYU BIO-TECNOLOGY CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 155. JINYU BIO-TECNOLOGY CO.,LTD Product
Table 156. JINYU BIO-TECNOLOGY CO.,LTD Recent Development
Table 157. Phibro Animal Health Corporation Information
Table 158. Phibro Animal Health Description and Business Overview
Table 159. Phibro Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 160. Phibro Animal Health Product
Table 161. Phibro Animal Health Recent Development
Table 162. ANHUI TIANKANG(GROUP)SHRES O., LTD Corporation Information
Table 163. ANHUI TIANKANG(GROUP)SHRES O., LTD Description and Business Overview
Table 164. ANHUI TIANKANG(GROUP)SHRES O., LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 165. ANHUI TIANKANG(GROUP)SHRES O., LTD Product
Table 166. ANHUI TIANKANG(GROUP)SHRES O., LTD Recent Development
Table 167. Zoetis Corporation Information
Table 168. Zoetis Description and Business Overview
Table 169. Zoetis Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 170. Zoetis Product
Table 171. Zoetis Recent Development
Table 172. WINSUN BIO Corporation Information
Table 173. WINSUN BIO Description and Business Overview
Table 174. WINSUN BIO Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 175. WINSUN BIO Product
Table 176. WINSUN BIO Recent Development
Table 177. PULIKE BIOLOGICAL ENGINERING,INC. Corporation Information
Table 178. PULIKE BIOLOGICAL ENGINERING,INC. Description and Business Overview
Table 179. PULIKE BIOLOGICAL ENGINERING,INC. Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 180. PULIKE BIOLOGICAL ENGINERING,INC. Product
Table 181. PULIKE BIOLOGICAL ENGINERING,INC. Recent Development
Table 182. Swine Reproductive and Respiratory Syndrome Vaccine Market Trends
Table 183. Swine Reproductive and Respiratory Syndrome Vaccine Market Drivers
Table 184. Swine Reproductive and Respiratory Syndrome Vaccine Market Challenges
Table 185. Swine Reproductive and Respiratory Syndrome Vaccine Market Restraints
Table 186. Swine Reproductive and Respiratory Syndrome Vaccine Customers List
Table 187. Swine Reproductive and Respiratory Syndrome Vaccine Distributors List
Table 188. Research Programs/Design for This Report
Table 189. Key Data Information from Secondary Sources
Table 190. Key Data Information from Primary Sources
List of Figures
Figure 1. Swine Reproductive and Respiratory Syndrome Vaccine Product Picture
Figure 2. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Type in 2020 & 2027
Figure 3. Active Vaccine Product Picture
Figure 4. Inactivated Vaccines Product Picture
Figure 5. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Application in 2020 & 2027
Figure 6. Government Tender
Figure 7. Market Sales
Figure 8. Swine Reproductive and Respiratory Syndrome Vaccine Report Years Considered
Figure 9. Global Swine Reproductive and Respiratory Syndrome Vaccine Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Swine Reproductive and Respiratory Syndrome Vaccine Market Size 2016-2027 (US$ Million)
Figure 11. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales 2016-2027 (K Units)
Figure 12. Global Swine Reproductive and Respiratory Syndrome Vaccine Market Size Market Share by Region: 2021 Versus 2027
Figure 13. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Region (2016-2021)
Figure 14. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Region in 2020
Figure 15. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Region (2016-2021)
Figure 16. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Region in 2020
Figure 17. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Share by Manufacturer in 2020
Figure 18. The Top 10 and 5 Players Market Share by Swine Reproductive and Respiratory Syndrome Vaccine Revenue in 2020
Figure 19. Swine Reproductive and Respiratory Syndrome Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 20. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Type (2016-2021)
Figure 21. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Type in 2020
Figure 22. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Type (2016-2021)
Figure 23. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Type in 2020
Figure 24. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Application (2016-2021)
Figure 25. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Application in 2020
Figure 26. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Application (2016-2021)
Figure 27. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Application in 2020
Figure 28. China Swine Reproductive and Respiratory Syndrome Vaccine Sales Growth Rate 2016-2027 (K Units)
Figure 29. China Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate 2016-2027 (US$ Million)
Figure 30. China Swine Reproductive and Respiratory Syndrome Vaccine Market Share in Global Market 2016-2027
Figure 31. China 5 and 10 Largest Swine Reproductive and Respiratory Syndrome Vaccine Players Market Share by Revenue in Swine Reproductive and Respiratory Syndrome Vaccine in 2020
Figure 32. China Swine Reproductive and Respiratory Syndrome Vaccine Revenue Share by Type (2016-2021)
Figure 33. China Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate by Type in 2016 & 2020
Figure 34. China Swine Reproductive and Respiratory Syndrome Vaccine Revenue Share by Application (2016-2021)
Figure 35. China Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate by Application in 2016 & 2020
Figure 36. North America Swine Reproductive and Respiratory Syndrome Vaccine Sales Growth Rate 2016-2021 (K Units)
Figure 37. North America Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 38. North America Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Country in 2020
Figure 39. North America Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Country in 2020
Figure 40. U.S. Swine Reproductive and Respiratory Syndrome Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 41. U.S. Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Canada Swine Reproductive and Respiratory Syndrome Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 43. Canada Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales Growth Rate 2016-2021 (K Units)
Figure 45. Europe Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 46. Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Country in 2020
Figure 47. Europe Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Country in 2020
Figure 48. Germany Swine Reproductive and Respiratory Syndrome Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 49. Germany Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 50. France Swine Reproductive and Respiratory Syndrome Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 51. France Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 52. U.K. Swine Reproductive and Respiratory Syndrome Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 53. U.K. Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 54. Italy Swine Reproductive and Respiratory Syndrome Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 55. Italy Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 56. Russia Swine Reproductive and Respiratory Syndrome Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 57. Russia Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 58. Asia Pacific Swine Reproductive and Respiratory Syndrome Vaccine Sales Growth Rate 2016-2021 (K Units)
Figure 59. Asia Pacific Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 60. Asia Pacific Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Region in 2020
Figure 61. Asia Pacific Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Region in 2020
Figure 62. China Swine Reproductive and Respiratory Syndrome Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 63. China Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 64. Japan Swine Reproductive and Respiratory Syndrome Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 65. Japan Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 66. South Korea Swine Reproductive and Respiratory Syndrome Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 67. South Korea Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 68. India Swine Reproductive and Respiratory Syndrome Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 69. India Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 70. Australia Swine Reproductive and Respiratory Syndrome Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 71. Australia Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 72. Taiwan Swine Reproductive and Respiratory Syndrome Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 73. Taiwan Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 74. Indonesia Swine Reproductive and Respiratory Syndrome Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 75. Indonesia Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 76. Thailand Swine Reproductive and Respiratory Syndrome Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 77. Thailand Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 78. Malaysia Swine Reproductive and Respiratory Syndrome Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 79. Malaysia Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 80. Philippines Swine Reproductive and Respiratory Syndrome Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 81. Philippines Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 82. Vietnam Swine Reproductive and Respiratory Syndrome Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 83. Vietnam Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 84. Latin America Swine Reproductive and Respiratory Syndrome Vaccine Sales Growth Rate 2016-2021 (K Units)
Figure 85. Latin America Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 86. Latin America Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Country in 2020
Figure 87. Latin America Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Country in 2020
Figure 88. Mexico Swine Reproductive and Respiratory Syndrome Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 89. Mexico Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 90. Brazil Swine Reproductive and Respiratory Syndrome Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 91. Brazil Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 92. Argentina Swine Reproductive and Respiratory Syndrome Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 93. Argentina Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 94. Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales Growth Rate 2016-2021 (K Units)
Figure 95. Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 96. Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Country in 2020
Figure 97. Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Country in 2020
Figure 98. Turkey Swine Reproductive and Respiratory Syndrome Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 99. Turkey Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 100. Saudi Arabia Swine Reproductive and Respiratory Syndrome Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 101. Saudi Arabia Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 102. UAE Swine Reproductive and Respiratory Syndrome Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 103. UAE Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 104. Swine Reproductive and Respiratory Syndrome Vaccine Value Chain
Figure 105. Channels of Distribution
Figure 106. Distributors Profiles
Figure 107. Bottom-up and Top-down Approaches for This Report
Figure 108. Data Triangulation
Figure 109. Key Executives Interviewed